Eye Cancer

Syndicate content

Mobile phone use not associated with eye melanoma

Mobile phone use is not associated with the risk of melanoma of the eye, researchers report in the January 13 online issue of the Journal of the National Cancer Institute.

Get the full story...

Interferon or Surgery for Eye Surface Cancer – Which is Best?

James Chodosh, MD, and colleagues evaluated 29 patients who were treated within a 10-year period for ocular surface squamous neoplasia (OSSN), a type of cancer, either by surgical removal of the tumor or with topical interferon (alfa-2b).

Get the full story...

New point of view on melanoma of the eye, at MUHC

Ocular melanoma is rarely detected before it has grown large enough to impair vision or to metastasize. This makes it a particularly challenging disease to fight, especially since chemotherapy is not very effective.

Get the full story...

St. Jude defines eye cancer gene's role in retinal development

A genetic discovery led by scientists at St. Jude Children’s Research Hospital helps answer a long-standing mystery about the eyes of vertebrates, and may translate into a deeper understanding of how genes coordinate the complex process of eye formation and how a rare pediatric eye cancer progresses.

Get the full story...

Specific cell that causes eye cancer, disproving long-held theory

Researchers found that certain mutations enable specific cells in the retina to multiply and cause eye cancer, a finding that suggests deliberate genetic manipulations might coax an injured brain to repair itself

Get the full story...

Immune deficiency linked to a type of eye cancer

The incidence of squamous cell eye cancer is greater among kidney transplant patients and people with human immunodeficiency virus (HIV) than the general public, which suggests the disease is associated with immune deficiency.

Get the full story...

St. Jude Announces Breakthrough In Eye Cancer Treatment

Scientists at St. Jude Children's Research Hospital have demonstrated in a mouse model a new, locally applied treatment for the eye cancer retinoblastoma that not only greatly reduces the size of the tumor, but does so without causing the side effects common with standard chemotherapy. The treatment also appears to be suitable for certain forms of breast, lung, prostate and colon cancer, and is simple enough for widespread use even in countries with limited resources.